Serum gets DCGI nod for Phase 2 & 3 trials

Unknown August 04, 2020 IFTTT, Times of India,

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

from Times of India https://ift.tt/39ZeN7J

About Unknown
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates.

No comments:

Post a Comment

About Us

We are offering and serving many kind material for social platform. News, Entertainment, Blog, Movies, TV, Social Activity. We are a part of the world of internet and information technology serving the human being for this era and try to serve the best idea, technology for move ahead. Learn with the fun and after serve the better and best. We did not never share your personal information for third party. Keep safe into our mind and feel free from us and we promise to you that you will be safe and secure for the future. We offer many more news channel for your interest and hobbies. We are a auto and self blogger's, where many opportunity for our readers and visitor. In future if possible we can arrange the some of good material for you.

Home Top Ad

Post Top Ad

Tuesday, August 4, 2020

Serum gets DCGI nod for Phase 2 & 3 trials

No comments:

Post a Comment

Post Top Ad

ihost1

Popular Posts

Latest News

Report Abuse

Featured Post

Nikki Haley Calls Trump ‘Unhinged’ and Dismisses Calls to Drop Out

Social

Recent

Popular

Comments

Archive

About Us

Wikipedia

Contact Form